News

Nipah virus vaccine from University of Tokyo set for April clinical trial

Pawpaw
Japan
Technology
Supply
Others
Published Feb 1, 2026

Tridge summary

TOKYO -- A Nipah virus vaccine candidate developed at the University of Tokyo is set to start clinical trials in Belgium in April.

Original content

Source: Nikkei

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.

What to read next

News
In-depth · Analysis | Under the global matcha wave, the peril and opportunity of Japan's tea industry Translation:
Foodmate · Feb 3, 2026
News
Biological decompaction advances in the field
Agrolink · Feb 5, 2026
News
"Lunar New Year lowers the burden of the shopping cart"
Fisheco · Feb 6, 2026
News
The Russian manufacturer of dairy ingredients is increasing exports following the exhibition in Dubai.
Oilworld · Feb 3, 2026
News
A wine treasure at the bottom of the sea: The first 800 bottles were extracted from the underwater caves of Las Grutas, with result
Bichos de campo · Feb 4, 2026

Read more relevant content

Opinion
Demand Shifts: Emerging Consumer Demand is Rebuilding Global Food Trade
Victor Langat · Feb 8, 2026
Opinion
Trade Regulation & Geopolitics: How 2025 Trade Policy Shifts Reconfigured Global Agricultural Markets
Victor Langat · Feb 8, 2026
Report
September 2025 Outlook Report: Coffee, Sugar, Tea, and Cocoa
Victor Langat · Sep 26, 2025
Report
September 2025 Outlook Report: Meat
Victor Langat · Sep 26, 2025
Opinion
US Apple Market Faces Record Harvest and Mounting Headwinds
Bojan Mijatovic · Sep 5, 2025
Opinion
Ecuador's Tango Mandarins Make Their US Debut After Five-Year Negotiation
Bojan Mijatovic · Aug 29, 2025
Opinion
Typhoon Kajiki’s Impact on Vietnamese Agriculture: Localized Rice Losses, Limited Coffee Disruption
Mzingaye Ndubiwa · Aug 28, 2025
Opinion
Impact of US Tariffs on EU Agriculture: Sectoral Impacts and Strategic Responses
Benjamin Lategan · Aug 22, 2025
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.